Health Canada has authorized Pfizer’s dual-value vaccine, adding another new COVID-19 shot to Canada’s arsenal that specifically targets the Omicron variant, which is currently the strain of the virus. dominate the world.
The vaccine also specifically deals with the BA.4 and BA.5 sub-variants of the Omicron variant. Health Canada previously approved Moderna’s two-way COVID-19 enhancer.
More will come.